SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001012477-24-000012
Filing Date
2024-05-08
Accepted
2024-05-08 09:16:38
Documents
68
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q avdl-20240331.htm   iXBRL 10-Q 810938
2 EX-31.1 exhibit311q12024.htm EX-31.1 10843
3 EX-31.2 exhibit312q12024.htm EX-31.2 10647
4 EX-32.1 exhibit321q12024.htm EX-32.1 5721
5 EX-32.2 exhibit322q12024.htm EX-32.2 5552
  Complete submission text file 0001012477-24-000012.txt   4445730

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT avdl-20240331.xsd EX-101.SCH 31955
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT avdl-20240331_cal.xml EX-101.CAL 63337
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT avdl-20240331_def.xml EX-101.DEF 98558
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT avdl-20240331_lab.xml EX-101.LAB 421166
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT avdl-20240331_pre.xml EX-101.PRE 281545
71 EXTRACTED XBRL INSTANCE DOCUMENT avdl-20240331_htm.xml XML 517120
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37977 | Film No.: 24924484
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)